Q Biotech Corp is a life sciences company dedicated to making high-quality biomolecule purification simple, fast, and
accessible. Founded in 2022 and headquartered in Rio Rancho, New Mexico, we design innovative tools that streamline
research and production workflows for proteins, RNA, and DNA.
Our flagship platform, the Inceptum™ personal chromatography system, combines fully automated operation with disposable
cartridges, eliminating the complexity, cleanup, and cross-contamination risks of traditional systems. Researchers can
move seamlessly from small-scale antibody purification to scalable workflows, with application-specific and open
cartridges tailored to their needs.
By uniting smart engineering with practical usability, Q Biotech helps scientists and manufacturers save time, reduce
errors, and accelerate discoveries.
Mission
Our mission is to design intuitive, innovative, and practical instruments that simplify the complexities of life science research. By removing repetitive bottlenecks in the lab, we enable researchers to devote more time to discovery and innovation, while helping organizations lower costs, increase productivity, and speed the transition from R&D to manufacturing.
Vision
We envision a future where protein and antibody purification is no longer a chore, but a seamless part of the scientific workflow. Born from real lab frustrations with spin columns and cumbersome purification systems, the Inceptum™ system delivers automation, reliability, and accessibility—paving the way for faster breakthroughs in research, diagnostics, and biomanufacturing.
Team
Sergey A. Dryga, PhD, MBA - CEO, Founder
Dr. Dryga is a seasoned business leader with strong technical background. He has built several high-performance R&D teams prior to starting Q Biotech Corp. His technical expertise encompasses such diverse areas as viral vectors, vaccine development, protein and nucleic acid purification, nanomaterials, in vitro diagnostics, semiconductor-based biosensor development and electronics, his inventions are protected by 36 issued US patents, over 40 applications and numerous international patents. In his role as Chief Scientific Officer and VP of Pilot Manufacturing at NanoDx, Inc. he led instrument, sensor and chemistry development for an in vitro diagnostics system which currently is in pre-clinical evaluation and manufacturing scale up. Sergey has strong experience in leading IP strategy, business development and interaction with investors, customers and other stakeholders, strategic planning and general management. Dr. Dryga founded Q Biotech Corp in November 2022 to implement and commercialize his patents-pending inventions in automated protein and nucleic acid purification that promise to revolutionize purification methods commonly used in biotechnology research.
Bob Evans, MBA - Vice President of Business Development
Bob has dedicated nearly his entire career to the Life Sciences field. He began by designing and manufacturing histopathology systems, then expanded his expertise to include molecular biology, PCR, vacuum concentrators, centrifuges, and various other laboratory instruments. He transitioned into marketing and business development roles for several large international companies managing North America sales for a Clinical Research Organization. Bob is originally from Liverpool in the United Kingdom and holds degrees in Mathematics, Electronics and an MBA from Dowling College.